Group 1: Mergers and Acquisitions - Haili Biological's subsidiary, Ruisheng Biological, plans to invest 61.2 million yuan to acquire 51% equity in seven dental chain companies located in Yangzhou and Changzhou, which is expected to increase the company's revenue by approximately 100 million yuan and net profit by over 7 million yuan [1] - Yanggu Huatai has decided to terminate the issuance of shares and cash payment to acquire 99.64% equity in Bomi Technology, opting to negotiate for partial equity acquisition in cash instead [2] - Yachuang Electronics intends to issue shares and pay cash totaling 317 million yuan to purchase 40% equity in Shenzhen Ouchuang Semiconductor and 45% equity in Shenzhen Yihai Nengda, constituting a major asset restructuring [3] Group 2: Earnings Forecasts - Guangku Technology anticipates a net profit attributable to shareholders of 169 million to 182 million yuan for 2025, representing a year-on-year growth of 152% to 172% [4] Group 3: Shareholding Changes - Jianzhijia's actual controller, Yunnan Xiangqun, plans to increase its stake in the company by up to 2% through a concentrated bidding process, with an investment amount of 50 million yuan sourced from its own funds and a loan of up to 45 million yuan from CITIC Bank [5] - Zhenzhong Investment, a significant shareholder of Lvdiaofeng, plans to reduce its stake by no more than 1% through a concentrated bidding process, equating to a maximum of 680,000 shares [6] - Two shareholders of Lingzhi Software plan to reduce their holdings by a combined total of up to 1.43%, with one shareholder reducing by up to 3.281 million shares (0.82% of total shares) and the other by up to 2.4492 million shares (0.61% of total shares) [7] Group 4: Tax Issues - Tianyue Advanced announced that it needs to pay a total of 82.9728 million yuan in corporate income tax and late fees, which will be recorded in the 2025 financial results, expected to reduce the company's net profit for that year [8] - China Pharmaceutical's wholly-owned subsidiary, Hainan Tongyong Sanyang Pharmaceutical and Hainan Kangli Pharmaceutical, received tax notices requiring a total payment of approximately 65.2178 million yuan in taxes and late fees, which will also impact the company's net profit for 2025 [9][10] Group 5: Regulatory Issues - Platelite has received a notice from the China Securities Regulatory Commission regarding a case of suspected illegal information disclosure, leading to an official investigation [11] Group 6: Legal Matters - Baotailong announced that its subsidiary, Shuangyashan Longmei Tiantai Coal Chemical Co., is involved in a significant lawsuit that has entered the second instance, with a ruling requiring it to pay 316 million yuan in contract price and interest, while also receiving compensation and a return of a quality guarantee deposit [12]

A 股证券代码：688234 证券简称：天岳先进 公告编号：2026-001 本事项不会影响公司的正常经营，敬请广大投资者注意投资风险。 港股证券代码：02631 证券简称：天岳先进 山东天岳先进科技股份有限公司 关于补缴税款的公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误 导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责 任。 山东天岳先进科技股份有限公司（以下简称"公司"）近期根据税务部门要求， 对涉税事项开展自查。现将有关情况公告如下： 一、基本情况 经自查，2019 年-2020 年应补缴企业所得税及滞纳金合计 8,297.28 万元。 二、对公司的影响及风险提示 根据《企业会计准则第 28 号——会计政策、会计估计变更和差错更正》相关 规定，上述补缴税款及滞纳金事项不属于前期会计差错，不涉及前期财务数据追 溯调整。公司补缴上述税款及滞纳金将计入 2025 年当期损益，预计相应减少公司 2025 年度净利润，最终以 2025 年度经审计的财务报表为准。 特此公告。 山东天岳先进科技股份有限公司董事会 2026 年 1 月 1 日 - 1 - ...

Core Viewpoint - Tianyue Advanced (688234) announced that it will pay a total of 82.9728 million yuan in corporate income tax and late fees for the years 2019-2020, as required by tax authorities, which will impact its net profit for 2025 [1] Group 1 - The company conducted a self-examination of tax-related matters as per the requirements of the tax authorities [1] - The total amount to be paid includes both corporate income tax and late fees [1] - The payment will be recorded in the financial results for the year 2025, leading to a reduction in the company's net profit for that year [1]

Core Viewpoint - The announcement details the expected daily related transactions for the year 2026 by Shandong Tianyue Advanced Technology Co., Ltd, emphasizing that these transactions are necessary for normal business operations and do not harm the interests of the company or minority shareholders [1][2]. Group 1: Daily Related Transactions Overview - The board of directors approved the expected daily related transactions for 2026, ensuring compliance with relevant laws and regulations, and independent directors confirmed the fairness and necessity of these transactions [3][11]. - The expected daily related transactions are essential for the company's normal production and business development, adhering to fair market principles [2][13]. - The company will not rely heavily on related parties, ensuring its independence is maintained [2][13]. Group 2: Transaction Details - The specific expected amount and categories of daily related transactions for 2026 are outlined, with amounts expressed in millions of RMB [5]. - The company can adjust transaction amounts among different related parties under the same control based on actual transaction conditions [6][12]. - Previous related transactions did not exceed the expected total amount, indicating a consistent execution of planned transactions [6]. Group 3: Related Parties Information - The related party, Jining Weishi Special Information Technology Development Co., Ltd, is controlled by the brother of the company's major shareholder, ensuring a clear connection [9]. - The company has followed the necessary procedures to exempt certain sensitive information from disclosure to protect competitive interests [4][8]. Group 4: Impact on Company Operations - The related transactions are regular and ongoing, beneficial for the company's operations and aligned with the interests of all shareholders [13]. - Pricing for related transactions is determined based on market prices and mutual agreement, ensuring no detriment to the company or minority shareholders [13]. - The transactions are not expected to significantly impact the company's operations or independence [13].

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected relative increase in stock price of over 20% compared to the benchmark index within the next six months [6][16]. Core Insights - The company is a leading player in the global wide-bandgap semiconductor materials industry, having achieved early industrialization of semi-insulating silicon carbide substrates and further advancing to conductive silicon carbide substrates [3][13]. - The company is expanding its production capacity, with the Jinan plant steadily increasing output through technological improvements, and the Shanghai Lingang plant achieving an annual production capacity of 300,000 conductive substrates ahead of schedule [3][4]. - The company has established a comprehensive product matrix for silicon carbide substrates, including 6/8/12-inch products, and is positioned to benefit from the industry's transition to a "12-inch era" [4][5]. - The company is actively expanding its applications in electric vehicles, renewable energy, and AI, having achieved significant partnerships with leading power semiconductor manufacturers and optical firms [5][6]. Financial Projections - Revenue projections for the company are estimated at 1.73 billion, 2.74 billion, and 3.80 billion yuan for the years 2025, 2026, and 2027 respectively, with net profits expected to be 33.19 million, 143.93 million, and 278.49 million yuan for the same years [10][11]. - The company is expected to experience significant growth in net profit, with a projected increase of 491.56% in 2025, followed by 333.71% in 2026, and 93.48% in 2027 [10][11].

现将具体情况公告如下： 一、日常关联交易基本情况 （一）日常关联交易履行的程序 2025 年 12 月 30 日，山东天岳先进科技股份有限公司（以下简称"公司"） 召开第二届董事会第十八次会议，审议通过了《关于公司 2026 年度日常关联交 易预计的议案》，关联董事回避表决，出席会议的非关联董事一致同意该议案。 表决程序符合《公司法》《证券法》等法律法规以及《公司章程》的有关规定。 | A | 股证券代码：688234 | 证券简称：天岳先进 | 公告编号：2025-080 | | --- | --- | --- | --- | | 港股证券代码：02631 | | 证券简称：天岳先进 | | 山东天岳先进科技股份有限公司 关于公司 2026 年度日常关联交易预计的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示 1、是否需提交股东大会审议：否 2、日常关联交易对上市公司的影响：本次预计关联交易事项为日常经营所 必需，遵循公平公允的市场原则和交易条件，不存在损害公司利益和中小股东利 益的情形，不会对关联方 ...

Core Viewpoint - The shareholder Hubble Technology Venture Capital Co., Ltd. has completed its share reduction plan for Tianyue Advanced, selling a total of 3,876,948 shares, which represents 0.80% of the company's total share capital, for a total amount of 315 million yuan [1] Summary by Sections Share Reduction Details - The share reduction occurred between October 28, 2025, and December 26, 2025, through centralized bidding [1] - The selling price ranged from 66.99 to 94.39 yuan per share [1] - After the reduction, Hubble Technology holds 23,385,552 shares, accounting for 4.83% of the total share capital [1] Compliance with Previous Plans - The actual reduction aligns with the previously disclosed reduction plan, confirming that the plan has been executed as scheduled [1]

Core Viewpoint - Hubble Technology Venture Capital Co., Ltd. has completed its share reduction plan for Tianyue Advanced Technology Co., Ltd., selling a total of 3.8769 million shares, which is 0.8% of the company's total share capital, for approximately 315 million yuan [1][4]. Group 1: Reduction Plan Background - Tianyue Advanced announced on September 27, 2025, that Hubble Investment planned to reduce its holdings by up to 387.6948 million shares, representing no more than 0.80% of the total share capital, due to internal decisions and exit needs [2]. - The reduction period was set from October 28, 2025, to December 26, 2025, starting 15 trading days after the announcement [2]. Group 2: Pre-Reduction Shareholding Situation - Before the reduction, Hubble Investment held 27.2625 million shares, accounting for 5.63% of the total share capital, all acquired prior to the company's initial public offering and listed for trading since January 12, 2023 [3]. Group 3: Reduction Plan Implementation Details - As of December 26, 2025, Hubble Investment completed its reduction plan, selling 3,876,948 shares at prices ranging from 66.99 to 94.39 yuan per share, totaling approximately 315.3 million yuan [4]. - After the reduction, Hubble Investment retained 23.3855 million shares, reducing its ownership percentage from 5.63% to 4.83%, while still being a major shareholder with over 5% ownership [4]. - The company stated that this reduction was a normal behavior based on the shareholder's funding needs and would not significantly impact the company's governance structure or ongoing operations [4].

Group 1 - Tianyue Advanced (SH 688234) announced on December 29 that shareholder Hubble Technology Venture Capital Co., Ltd. has completed a share reduction plan, reducing approximately 3.8769 million shares, accounting for 0.8% of total shares [1] - As of the announcement, Tianyue Advanced has a market capitalization of 44.6 billion yuan [1] Group 2 - A new type of chip has been developed in China, which bypasses the limitations of lithography machines, supporting AI training and embodied intelligence, and can be mass-produced using mature processes of 28 nanometers and above [1]

Core Viewpoint - Hubble Technology Venture Capital Co., Ltd. has completed its share reduction plan for Tianyue Advanced Technology Co., Ltd., selling a total of 3.8769 million shares, which is 0.8% of the company's total share capital, for approximately 315 million yuan [1][4]. Group 1: Background of the Reduction Plan - Tianyue Advanced announced on September 27, 2025, that Hubble Investment planned to reduce its holdings by up to 3.8769 million shares, representing no more than 0.8% of the total share capital, due to internal decisions and exit needs [2]. - The reduction period was set from October 28, 2025, to December 26, 2025, starting 15 trading days after the announcement [2]. Group 2: Shareholding Situation Before Reduction - Before the reduction, Hubble Investment held 27.2625 million shares, accounting for 5.63% of the total share capital, all of which were acquired prior to the company's initial public offering and became tradable on January 12, 2023 [3]. Group 3: Details of the Reduction Plan Implementation - The reduction was completed by December 26, 2025, with Hubble Investment selling 3,876,948 shares at prices ranging from 66.99 to 94.39 yuan per share, totaling approximately 315.3 million yuan [4]. - After the reduction, Hubble Investment retained 23.3855 million shares, reducing its ownership percentage from 5.63% to 4.83%, while still being a major shareholder with over 5% ownership [4]. - The company stated that this reduction was a normal behavior based on the shareholder's funding needs and would not significantly impact the company's governance structure or ongoing operations [4].